Summary We demonstrated that four human oesophageal squamous cell carcinoma cell lines (TE8, TE9, TEIO and TEl1) produced matrix metalloproteinase-I (proMMP-1/tissue collagenase), 2 (ProMMP-2/'type IV collagenase'), 3 (proMMP-3/stromelysin), and 9 (proMMP-9/92-kDa gelatinase) as members of a matrix metalloproteinase (MMP) family, which degrades extracellular matrix macromolecules. Under normal culture conditions, in immunoblot analysis, proMMP-1 of M, = 53,00 was detected in one cell line (TE8), proMMP-2 of Mr = 72,000 in three cell lines (TE9, TE1O, and TEl 1), and proMMP-3 of M, = 57,000 in all four cell lines. In addition to these enzymes, in enzymography, a gelatinolytic activity around M,= 92-kDa, likely to be proMMP-9, was detected in only one cell line (TEIO) under normal culture conditions. When these cell lines were treated with epidermal growth factor (EGF), however, the agent stimulated three cell lines (TE8, TEIO and TEl 1) to produce proMMP-9 in a dose-dose dependent manner. Oesophageal carcinoma-conditioned medium stimulated oesophageal fibroblasts to produce proMMP-1, -2, and -3, suggesting that the interaction between oesophageal carcinoma and stromal fibroblasts also plays a role in the production of MMPs by the latter.
Destruction or penetration of the basement membrane is thought to be an essential step in successful metastasis by tumour cells (Goldberg et al., 1990; Liotta et al., 1986; Murphy et al., 1989) . Thus, enzymes that can degrade extracellular matrix macromolecules, including basement membrane components, are believed to play an important role in the process of tumour invasion and metastasis. Recently, many research groups have proposed that invasive tumour cells secrete matrix-degrading proteinases, such as matrix metalloproteinases (MMPs) , plasminogen activator (Dano et al., 1985; Niedabala & Sartorelli, 1989) , and cathespins (Sloane & Honn, 1984) . In particular, the MMP family, including MMP-1 (tissue collagenase [Welgus et al., 1981] ), MMP-2 (72-kDa gelatinase/'type IV collagenase' [Murphy et al., 1985; Okada et al., 1990] ), and MMP-3 (stromelysin [Okada et al., 1986] ), is closely associated with the process of tumour invasion and metastasis (Irimura et al., 1987; Liotta, 1986; Monteagudo et al., 1990; Reich et al., 1988) . In our previous study (Shima et al., 1992) , we also found that MMPs play an important role in the metastasis of oesophageal squamous cell carcinoma: immunohistochemical examination demonstrated that the expression of MMPs is correlated with tumour invasion and lymph node metastasis of the oesophageal carcinoma.
Several studies have shown that the production of MMP-1 and -3 by mouse or human fibroblasts may be stimulated by epidermal growth factor (EGF), platelet-derived growth factor (PDGF), transforming growth factor-a (TGF-x), and tumour promoters such as 12-O-tetradecanoyl-phorbol-13-acetate (TPA) (Chua et al., 1985; Kerr et al., 1988) . We have also reported that proMMP-1 production by vascular smooth muscle cells or proMMP-3 production by stromal cells of giant cell tumour of bone is stimulated by PGDF, interleukin 1, and/or TPA . These findings strongly suggest that the production of MMPs by oesophageal carcinoma may be regulated by growth factors such as EGF and/or TGF-a and that the expression of MMPs and EGF receptors may be closely associated with the malignant potential of oesophageal carcinoma. In fact, overexpression of EGF receptors is a common property of oesophageal carcinoma Yamamoto et al., 1986) ; and TGF-a as well as EGF binds to the EGF receptor on the same cell surface, although TGF-o is only half as efficient as EGF (Derynck et al., 1987) .
In the present study, we first demonstrate the ability of human oesophageal squamous carcinoma cell lines to produce MMPs and then examine the effects of EGF on MMP production by these cell lines. We also discuss the role of MMPs in the malignant potential of squamous cell carcinoma.
Materials and methods
Cell culture Squamous carcinoma cell lines (TE8, TE9, TE1O and TEl 1) derived from human oesophageal carcinomas (Akaishi, 1984; Akaishi et al., 1988) DMEM containing one of various concentrations of EGF (Wako Pure Chem. Ind. Ltd., Osaka, Japan) was added to each dish. After incubation for 3 days, the medium was collected and used for Western blot analysis and gelatinzymography, as described previously (Morodomi et al., 1992; Yanagi et al., 1991) . The serum-free conditioned medium was first subjected to sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions and then electrotransferred to a microcellulose filter (0.45 micron pore size) at 200mA for 2 h at 4°C. Reconstituted non-fat dried milk (20%, W/V) was used in the blocking step as described previously Yanagi et al., 1991) . The filter was treated for 4h at room temperature with sheep anti-(human proMMP-1) serum, rabbit anti-(human proMMP-2) or sheep anti-(human proMMP-2) serum, or sheep anti-(human MMP-3) serum, all gifts from Dr H. Nagase (Okada et al., 1986 (Okada et al., , 1989 Sasaguri et al., 1992 Sasaguri et al., , 1991 Yanagi et al., 1991) . After extensive washing, the filter was incubatd with alkaline phosphatase-conjugated rabbit anti-(sheep IgG) IgG or goat anti-(rabbit IgG) IgG for 4h at room temperature. Immunoreactivity of MMPs was visualised with 5-bromo-4-chloro-3-indolyl phosphate disodium salt (BCIP) and nitroblue tetrazolium chloride (NBT) in carbobionate buffer. Prestained protein standards (Bio Rad Lab., Richmond, CA) were used for the estimation of Mr.
Gelatinolytic activity was determined by SDS-PAGE under reducing conditions with a 10% polyacrylamide gel of 1-mm thickness containing gelatin (0.8 mg ml-') as described previously (Morodomi et al., 1992; Sasaguri et al., 1992; Yanagi et al., 1991) . The serum-free conditioned medium, untreated or treated with IlM-4-aminophenylmercuric acetate (APMA), was mixed with SDS sample buffer; and after electrophoresis, the gel was gently shaken in 50 mM Tris-HCI buffer (pH 7.5)/5 mM Ca2+/1 ltM Zn2+/1% Triton X-100/ 0.02% NaN2 for 3 days at room temperature. For visualisation of gelatinolytic activities, the gels were incubated in 0.02% Coomassie brilliant blue R-250 for 1 h. The activities were detected as zones of negative staining with the dye.
Immunofluorescence of MMPs in cultured cells
For immunofluorescence staining, oesophageal carcinoma cells were seeded on Lab Tek chamber slides (Nunc, Inc, Naperville, IL) and incubated with 1 jig ml -of monensin (Sigma Chem. Co., St. Louis, MO) for 16 h prior to fixation with cold 95% acetone for 1 min, as described previously . After incubation with oesophageal carcinoma-conditioned medium for 2 days, oesophageal fibroblasts were also tested by immunofluorescence staining. They were dried by air and rehydrated with PBS. After incubation with the first antibody for 1 h at room temperature, the specimens were washed with PBS followed by incubation with fluorescent isothiocyanate (FITC)-conjugated rabbit anti-(sheep IgG) IgG or goat anti-(rabbit IgG) IgG for 1 h at room temperature. These specimens were finally overlaid with glycerin and observed under an Olympus immunoflourescence microscope.
Results
Production of MMPs by oesophageal squamous cell carcinoma lines Serum-free conditioned-medium from each cell line was applied to immunoblot analysis. As shown in Figure 1 , the production of proMMP-2 of M, = 72,000 was detected in TE9, TElO, and TEl ( Figure lb) ; and that of proMMP-3 of Mr= 57,000, in all four carcinoma cell lines (Figure 1c ), whereas proMMP-1 of Mr = 53,000 was detected only in TE8
( Figure la) . Immunofluorescence microscopy demonstrated the presence of these enzymes in the cells (Figure 2 ). Although the antibody against proMMP-2 shows slight cross-reactivity with proMMP-9, as previously reported (Morodomi et al., 1992) , in this immunoblot examination no proMMP-9 band was detected with any of the cell lines, suggesting that the amount of proMMP-9 produced under normal culture conditions is very little. Fluorescence of proMMP-1 was observed in TE8 (Figure 2a Gelatinolytic activities in conditioned-medium To investigate gelatinolytic activity, we analysed serum-free conditioned-medium from each cultured cell line by gelatinzymography ( Figure 3 ). TE9 (Figure 3 -2) expressed two major gelatin-cleaving activities, which were attributed to proMMP-3 of Mr = 57,000 and proMMP-2 of Mr = 72,000.
TE8 (Figure 3-1) and TEl 1 (Figure 3-4) expressed minor a gelatin-cleaving activity at Mr = 57,000 or two activities at Mr = 57,000 and Mr = 72,000 respectively. TEIO (Figure 3-3 ) expressed one major gelatin-cleaving activity of Mr= 57,000 corresponding to proMMP-3, and two additional minor gelatin-cleaving activities at M, = 72,000 and Mr = 92,000, which corresponded to proMMP-2 and proMMP-9, respectively. These data are also in parallel with the results of immunoblotting except for proMMP-9.
Effect of EGF on the production of MMPs To investigate the effect of EGF on MMP production by these cell lines, we analysed the conditioned media by gelatinzymography after the cell lines had been incubated with various concentrations of EGF for 3 days. EGF markedly stimulated TEIO to produce proMMP-9, while the effect of the growth factor on the production of proMMP-2 and -3 by this line was negligible (Figure 4b ). Moreover, EGF also slightly stimulated TE8 and TE 11 to increase the gelatinolytic activity of MMP-9 (Figure 4a and c), whereas its activity in these two cell lines was undetectable in the absence of the growth factor. TE9 was unaffected by EGF in terms of gelatinolytic activity. In our previous paper (Morodomi et al., 1992) , we reported the characterisation of matrix metalloproteinase 9 from U937 monocytic leukaemia. The major gelatinolytic activity from TEIO was similar to that from U937 ( Figure 5 ). Effect of oesophageal carcinoma-conditioned medium on proMMP-J, -2 and -3 Oesophageal fibroblasts were incubated with oesophageal carcinoma-conditioned medium for 2 days, and the production of proMMP-1, -2, and -3 in the cells was tested by antibodies against these enzymes.
Immunoflourescence staining showed that the oesophageal carcinoma-conditioned medium from TE9 stimulated fibro- (Shima et al., 1992) .
Non-neoplastic normal cell, such as fibroblasts (Collier et al., 1988) , vascular smooth muscle cells , and endothelial cells (Kalebic et al., 1983) (Uitto et al., 1980) or macrophages (Garbisa et al., 57k 1986) , indicating that the ability to produce such enzymes may be one of the key requirements for these inflammatory cells to migrate from peripheral blood to the inflammatory site. It was also reported that proMMP-9 is secreted by transformed cell lines originating from fibroblasts (Wilhelm et al., 1989) and by several tumour cells (Ballin et al., 1988; Yamagata et al., 1988) . In a previous study (Morodomi et al., 1992) , we reported that activated MMP-9 from U937 monocytic leukaemia and HT1080 fibrosarcoma digests gelatin, collagen type V, reduced-carboxymethylated transferrin, 2 3 4 5 c type IV collagen, and laminin A chain. In the present study, upon zymography, we also found that the production of the 92k enzyme of M, = 92,000 was demonstrable in three cell lines. These results on zymography indicated that the enzyme of .~~~~M r =92,000 was identical to proMMP-9 from U937. Since
unlike proMMP-1, -2 and/or -3, detectable amounts of _-l57k proMMP-9 are not produced by normal cells such as fibroblasts, we consider the production of proMMP-9 to be one of the most important factors for migration of tumour cells into the bloodstream or lymphatic vessels, or into adjacent normal tissues. It stands to reason that proMMP-9-mediated enzymatic degradation of type IV collagen and laminin, which are the most important basement membrane components, has been implicated in invasive and metastatic growth (Ballin et al., 1988; Lyons et al., 1991) . The results from immunofluorescence staining of oesophact of EGF on produciton of MMPs by oesophageal geal fibroblasts, which had been cultured in oesophageal carcinoma lines. Except for TE9, EGF markedly carcinoma-conditioned medium, suggested that oesophageal a, TEIO b, and TEll c to produce proMMP-9 of carcinoma cell produced some factor(s) that stimulates vhile the growth factor fails to augment the prodstromal fibroblasts to secrete proMMP-1, -2 and -3. In our MMP n1 -2 and -3 by any of the cell lines. 1, previous paper (Shima et al., 1992) , we observed by immuno1ng ml', 3, lOng ml ; 4, 50Engml-'; 5 histochemical staining that the amount of proMMP-l, -2 and * EGF.
-3 produced by carcinoma cells in tissues was larger than that by stromal fibroblasts. We also considered, however, that the interaction between oesophageal carcinoma and stromal fibroblasts plays a role in the production of MMPs by the ace proMMP-2 and -3 ( Figure 6 ) and that to a latter.
-he conditioned medium from TE8, TEIO, and In the present study, EGF stimulated squamous cell carrhtly stimulated the production of proMMP-l cinoma cell lines to produce proMMP-9, but not proMMP-l, ymography, the stimulation of production of -2 and -3. Interestingly, it has been reported that squamous fibroblasts was not detected.
carcinoma cell display overexpression of EGF receptors Yamamoto et al., 1986; Ozawa et al., 1987) . These studies suggest that EGF and its receptors are one of the regulatory factors for the production of proMMP-9. Ozawa et al. (1987) and Ozanne et al. (1986) Kerr et al. (1988) have described that proMMP-3 gene expression is regulated by PDGF in a c-fos-dependent manner and by EGF in a manner independent of c-fos and that the stimulatory effect of both PDGF and EGF on proMMP-3 transcription involves factors that recognise the promoting region (AP-1 site), which they reported to be a binding site for the transcriptional factor Jun/Fos complex. It is known that the increasing binding of the transcriptional factor to the AP-1 site of proMMP-1, -3 and -9 genes results in an increase in transcription of these genes (Angel et al., 1987; Huhtalal et al., 1991) , whereas the MMP-2 gene does not contain the AP-1 binding region in its upstream (Huhtala et al., 1990) . Our previous study has described that the production of proMMP-2 and -3 by giant cell tumour of bone was stimulated by cytokines, whereas the Figure 6 Immunofluoresence assay for the effect of squamous cell carcinoma-conditioned medium from TE9 on the production of proMMP-2 and -3 by oesophageal fibroblasts. The squamous cell carcinoma-conditioned media from TE9 stimulate oesophageal fibroblasts to produce proMMP-2 (b and e) and -3 (c and f), but fails to stimulate the production of proMMP-l (a and d) by them. a, b, and c: serum-free DMEM; c, d and f: serum-free DMEM containing 50% oesophageal carcinoma-conditioned medium.
Bar= 10lgm. production of proMMP-l by the tumour was not detected. Furthermore, unlike proMMP-1 and -3, proMMP-9 is physiological secreted by neutrophils and macrophages to aid in their migration from blood into tissue, but not by other normal cells such as normal fibroblasts. The above data strongly indicate that the mechanism of regulation of the production of MMPs differ according to the proteinase and the cell type that is involved.
In conclusion, we have shown that oesophageal carcinoma cells may be stimulated by EGF to produce large amounts of proMMP-9, the production of which is mediated by overexpressed EGF receptors, and which results in pronounced destruction of stromal tissue. Thus, we conclude that MMP production or EGF-EGF receptor-stimulated proMMP-9 production by oesophageal carcinoma, in particular, may play an important role in the invasion and metastasis of such cancers and that the analysis of MMP expression in tissues is useful for evaluation of the metastatic potential of individual squamous cell carcinomas.
